Skip to main content

Coronavirus (COVID-19) Updates: Visitation Policies (New! 11.25.20) | How We're Keeping You Safe | Latest COVID Information

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
New Cohort Discovery Tools Available to UR Researchers Via TriNetX

New Cohort Discovery Tools Available to UR Researchers Via TriNetX

University of Rochester researchers can now access a new set of analytic tools and an expanded network database of over 60 million patients through TriNetX, a cohort discovery tool launched at the university last year.

Dipping Our Toes in Rising Waters: UR CTSI Joins Planetary Health Alliance

Dipping Our Toes in Rising Waters: UR CTSI Joins Planetary Health Alliance

Climate and environmental changes are some of the biggest threats to human health today. To better understand and address these issues, the UR CTSI has joined the Planetary Health Alliance, opening up a wealth of resources for University of Rochester researchers.

Use the COVID-19 Biobank to Support Your Coronavirus Research

Use the COVID-19 Biobank to Support Your Coronavirus Research

University of Rochester research faculty and staff can request access to thousands of COVID-19-positive and -negative blood specimens and associated, de-identified clinical data through the COVID-19 Biobank. See what the Biobank has to offer and submit a request today.  

UR CTSI Broadens Patient Cohort Discovery Capability at UR Through ACT Network

UR CTSI Broadens Patient Cohort Discovery Capability at UR Through ACT Network

University of Rochester researchers can now query de-identified data from 125 million patients across the country to validate the feasibility of their clinical trials and find collaborators for multi-site trials through the ACT Network.

Past Pilot Awardee Granted $2M to Develop Better Statistics to Measure MicroRNA

Past Pilot Awardee Granted $2M to Develop Better Statistics to Measure MicroRNA

With his first R01, Matthew McCall, Ph.D., will continue research that was previously funded by the UR CTSI. He aims to develop statistical methods to measure expression levels of microRNAs, which impact many human diseases.